Home>>Signaling Pathways>> Neuroscience>> Monoamine Oxidase>>Isocarboxazid

Isocarboxazid (Synonyms: NSC 169893, Ro 5-0831)

Catalog No.GC31104

An inhibitor of MAO

Products are for research use only. Not for human use. We do not sell to patients.

Isocarboxazid Chemical Structure

Cas No.: 59-63-2

Size Price Stock Qty
5mg
$82.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Isocarboxazid is a non-selective and irreversible inhibitor of monoamine oxidase, with an IC50 of 4.8 μM for rat brain monoamine oxidase in vitro[1].

Isocarboxazid (1, 3 mg/kg, i.p., 60 min) pretreatment in mice shows the significant increased number of head twitches at 15 and 30 min after 5-HTP[2].Isocarboxazid (1, 3 mg/kg, i.p., 60 min) treatment in mice together with 5-HTP administration causes 43% 5-HT concentration increased and 22% of 5-HIAA decreased compared to brain concentrations in mice given 5-HTP alone[2].|| Animal Model:|Twelve male mice of dd strain (20-25 g)[2]|Dosage:|0, 0.3,1, 3 mg/kg|Administration:|Intraperitoneally 60 min before intravenous injection of 5-HTP|Result:|The number of head twitches at 15 and 30 min after 5-HTP was increased.43% 5-HT concentration increased and 22% of 5-HIAA decreased.

[1]. MAXWELL DR, et al. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo. Br J Pharmacol Chemother. 1961 Dec;17:310-20.

Reviews

Review for Isocarboxazid

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Isocarboxazid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.